Evidence map›Paper›PMID 27056269›Full record

ArticleThe Journal of allergy and clinical immunology2016

T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity.

Peter Szodoray, Stephanie M Stanford, Øyvind Molberg, Ludvig A Munthe, Nunzio Bottini, Britt Nakken

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Multipartite Fluorogenic Sensors for Monitoring Tyrosine Phosphatase Activity.Chembiochem : a European journal of chemical biology · 2024
    Article
  3. Article
  4. PeerJ · 2024
    Article
  5. Review
  6. Article
  7. SARS-CoV-2 infection relaxes peripheral B cell tolerance.The Journal of experimental medicine · 2022
    Article
  8. Article
  9. Article
  10. Fluorogenic probes for imaging cellular phosphatase activity.Current opinion in chemical biology · 2020
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Peter SzodorayCentre for Immune Regulation, Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo, Norway. Electronic address: peter.szodoray@medisin.uio.no.
Stephanie M StanfordDivision of Cellular Biology, La Jolla Institute for Allergy and Immunology, La Jolla, Calif.
Øyvind MolbergDepartment of Rheumatology, Oslo University Hospital-Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ludvig A MuntheCentre for Immune Regulation, Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Nunzio BottiniDivision of Cellular Biology, La Jolla Institute for Allergy and Immunology, La Jolla, Calif.
Britt NakkenCentre for Immune Regulation, Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo, Norway.
Oslo University Hospital · NOLa Jolla Institute for Immunology · US

Funding

Fluorogenic Assays for Cell-based HTS of Tyrosine Phosphatase InhibitorsR01DK080165 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOTTINI, NUNZIO · 2008 to 2012
$1.5M
NIDDK NIH HHS R01 DK080165
6 · The paper itself

Abstract

backgroundWe recently identified a human B-cell population that is naturally autoreactive and tolerized by functional anergy (BND cells).

objectiveWe sought to identify the molecular mechanism of how anergic autoreactive BND cells escape functional anergy and whether this process is altered in patients with lupus.

methodsIsolated peripheral blood naive and BND cells were cultured with various stimuli, and their activation status was determined by using an intracellular Ca(2+) mobilization assay. Lyn kinase and Syk activities were assessed by using phospho-flow analysis. CD45 phosphatase activity was determined by using a novel flow-based assay, which takes advantage of the fluorogenic properties of phosphorylated coumaryl amino propionic acid, an analog of phosphotyrosine, which can be incorporated into peptides. Real-time quantitative PCR was used to quantitate LYN, SYK, and CD45 mRNA.

resultsT-helper signals reversed the state of anergy, allowing BND cells to fully respond to antigenic stimulation by restoring signaling through the B-cell receptor (BCR). The mechanism was dependent on increased activity of the tyrosine phosphatase CD45 and CD45-dependent activation of Lyn and Syk. CD45 phosphatase activity was increased by T-cell help both in BND and naive B cells. Furthermore, we found that BND cells obtained from patients with systemic lupus erythematosus exhibited increased CD45 activity and BCR-signaling capacity, thus being less tolerized than BND cells from healthy control subjects.

conclusionOur findings suggest that CD45 is a key regulator of BCR-signaling thresholds mediated by T-cell help. This raises the possibility that BND cells could represent precursors of autoantibody-secreting plasma cells and suggests a role for these autoreactive B cells in contributing to autoimmunity if not properly controlled.

Indexed as

AdultB-LymphocytesCalciumCells, CulturedClonal AnergyHumansLeukocyte Common AntigensLupus Erythematosus, SystemicReceptors, Antigen, B-CellRNA, MessengerSignal Transductionsrc-Family KinasesSyk KinaseT-LymphocytesUp-RegulationCalciumLeukocyte Common Antigenslyn protein-tyrosine kinasePTPRC protein, humanReceptors, Antigen, B-CellRNA, Messengersrc-Family KinasesSyk KinaseSYK protein, humanB-cell anergybreak of toleranceCD45 phosphatase activitysystemic lupus erythematosusT-cell help

Identifiers

PMID27056269
PMCPMC12892367
OpenAlexW2340566270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.